Boston Scientific Filterwire EZ
This article was originally published in The Gray Sheet
Domestic launch of next-generation embolic protection filter system for use in angioplasty and stent treatment of diseased saphenous vein grafts is announced Aug. 23 following FDA 510(k) clearance. Building on the first-generation Filterwire EX, launched in the U.S. in June 2003, the EZ debuted overseas last September featuring an updated "suspended loop" filter support design to enhance deliverability and effectiveness, Boston Scientific claims. The 510(k) was supported by the 90-patient BLAZE multi-center clinical registry. Separately, the firm reports FDA market go-ahead for its Peripheral Cutting Balloon angioplasty system. Featuring longitudinally mounted microsurgical blades, the device is intended to treat blocked hemodialysis access grafts in end-stage renal disease patients. The system requires less pressure and trauma than conventional angioplasty, the firm says...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.